OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 115, Issue 6, Pages e21-e25 (June 2008)


View previous. 29 of 43 View next.

En Bloc Perfluorodissection for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

Presented in part at: American Academy of Ophthalmology Annual Meeting, November, 2007, New Orleans, Louisiana.

J. Fernando Arevalo, MD, FACSCorresponding Author Informationemail address

Received 11 October 2007; received in revised form 19 December 2007; accepted 8 February 2008. published online 17 April 2008.

Objective

En bloc perfluorodissection (EBPD) is a surgical dissection technique that facilitates removal of epiretinal membranes and the posterior hyaloid. It is carried out by injecting perfluorocarbon liquid between the retina and the posterior hyaloid to separate the epiretinal tissues from the subjacent retina. The objective of this study was to describe the technique and to demonstrate the applicability of using EBPD during vitrectomy in eyes with tractional retinal detachment (TRD) in proliferative diabetic retinopathy (PDR).

Design

Prospective, interventional case series.

Participants

Fifty-seven patients (eyes) with TRD in PDR participated in the study.

Methods

The author performed EBPD in 57 eyes (consecutive patients) during vitrectomy for TRD in severe PDR. Mean age of the patients was 42 years (range, 23–84 years). Mean surgical time was 50 minutes (range, 40–75 minutes). The group of patients was followed up for a mean of 18 months (range, 8–26 months).

Main Outcome Measures

Best-corrected visual acuity (BCVA), retinal status, and complications at the end of follow up.

Results

None of the patients have developed ocular hypertension or undue inflammation, and anatomic success—accompanied by visual improvement (≥2 Early Treatment Diabetic Retinopathy Study [ETDRS] lines) in 70.1% (40/57)—occurred in 100% (57/57) of eyes. In 14 eyes (24.5%), BCVA remained stable, and in 3 eyes (5.2%), BCVA decreased (≥2 ETDRS lines). Final BCVA was 20/50 or better in 25%, between 20/60 and 20/400 in 47%, and worse than 20/400 in 28%. Complications included phthisis bulbi in 1 (1.7%) eye, iatrogenic retinal breaks in 4 (7%) eyes, vitreous hemorrhage requiring another procedure in 4 (7%) eyes, and cataract in 15 (26.3%) eyes.

Conclusions

This report demonstrates the applicability of using EBPD during vitrectomy in eyes with TRD in PDR.

Available online: April 17, 2008.

Retina and Vitreous Service, Clinica Oftalmológica Centro Caracas, Caracas, Venezuela.

Corresponding Author InformationCorrespondence to J. Fernando Arevalo, MD, FACS, Clinica Oftalmologica Centro Caracas, Edif. Centro Caracas PH-1, Av. Panteon, San Bernardino, Caracas 1010, Venezuela.

 Manuscript no. 2007-1330.

 Supported in part by the Arevalo-Coutinho Foundation for Research in Ophthalmology, Caracas, Venezuela.

 The author has no proprietary or financial interest in any products or techniques described in this article.

PII: S0161-6420(08)00123-1

doi:10.1016/j.ophtha.2008.02.008


View previous. 29 of 43 View next.